| Date: | 2010-08-30 |
| Acquiring pharma company: | Lonza (Switzerland) |
| Acquired biotech company: | Vivante GMP Solutions (USA) |
| Amount: | |
| Terms of the agreement: | Lonza has purchased Vivante GMP Solutions, an American custom manufacturing organization dedicated to producing GMP viral-based therapeutics. This acquisition allows Lonza to broaden its biologics custom service offering for the viral vaccine and gene therapy markets. |
| Other: |
